Literature DB >> 9722726

Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing.

G M Saed1, D Ladin, J Olson, X Han, Z Hou, D Fivenson.   

Abstract

BACKGROUND: Keloids are the result of a dysregulated wound healing process. They are characterized by the formation of excess scar tissue that proliferates beyond the boundaries of the original wound. Somatic mutations of p53 have been implicated as causal events in up to 50% of all human malignancies. In addition, p53 has been shown to play an important role in controlling cell proliferation and apoptosis. We hypothesize that mutations in p53 can lead to a hyperproliferative state that can result in keloid formation.
OBJECTIVE: To detect p53 DNA mutations in tissues and cultured fibroblasts from skin lesions of 7 patients with keloids.
DESIGN: The polymerase chain reaction followed by single-strand conformational polymorphism analysis and direct DNA sequencing were used to detect p53 gene mutations.
SETTING: The Department of Dermatology, Henry Ford Hospital, Detroit, Mich. PATIENTS: Seven patients with keloids seen for routine surgical excision of their lesions. Normal DNA specimens were obtained from buccal smears and healthy skin samples from these patients.
RESULTS: Mutations in the p53 were identified in all patients by polymerase chain reaction followed by single-strand conformational polymorphism analysis and subsequently confirmed by DNA sequencing. A mutation in exon 5 resulting in amino acid substitution was found in 1 of the patients in keloid tissue and cultured keloid fibroblasts (codon 156, CGC-->CCC, arginine-->proline). Frameshift mutations in exons 5 and 6 caused by the insertion or deletion of a nucleotide at different positions were found in 6 patients with keloids in both keloid tissues and cultured fibroblasts. Mutations in exon 4 resulting in amino acid substitution were found in all patients in both keloid tissues and cultured fibroblasts (all in codon 72, CGC-->CCC, arginine-->proline). No p53 mutations were detected in buccal smears or cultured fibroblasts from healthy skin samples of any of the patients.
CONCLUSIONS: Focal mutations in p53 may increase cell proliferation and decrease cell death in the dysregulated growth patterns that have been clinically documented. An understanding of the pattern of all growth dysregulation related to keloids may lead to new therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9722726     DOI: 10.1001/archderm.134.8.963

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  17 in total

Review 1.  Molecular therapy in ocular wound healing.

Authors:  M F Cordeiro; G S Schultz; R R Ali; S S Bhattacharya; P T Khaw
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

2.  Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways.

Authors:  Joan C Smith; Braden E Boone; Susan R Opalenik; Scott M Williams; Shirley B Russell
Journal:  J Invest Dermatol       Date:  2007-11-08       Impact factor: 8.551

3.  Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance.

Authors:  T Chodon; T Sugihara; H H Igawa; E Funayama; H Furukawa
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

4.  Epigenetically altered wound healing in keloid fibroblasts.

Authors:  Shirley B Russell; James D Russell; Kathryn M Trupin; Angela E Gayden; Susan R Opalenik; Lillian B Nanney; Alan H Broquist; Latha Raju; Scott M Williams
Journal:  J Invest Dermatol       Date:  2010-06-17       Impact factor: 8.551

Review 5.  Scleroderma-like cutaneous syndromes.

Authors:  Yasuji Mori; Veli-Matti Kahari; John Varga
Journal:  Curr Rheumatol Rep       Date:  2002-04       Impact factor: 4.592

6.  Role of Hyaluronic Acid Treatment in the Prevention of Keloid Scarring.

Authors:  Andrea Hoffmann; Jessica Lynn Hoing; Mackenzie Newman; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2013-07-01

7.  Expressions of Collagen I and III in Hypoxic Keloid Tissue.

Authors:  Endah Wulandari; Sri Widia A Jusman; Yefta Moenadjat; Ahmad A Jusuf; Mohamad Sadikin
Journal:  Kobe J Med Sci       Date:  2016-07-25

8.  Differential apoptosis markers in human keloids and hypertrophic scars fibroblasts.

Authors:  Bruna De Felice; Corrado Garbi; Margherita Santoriello; Alessandra Santillo; Robert R Wilson
Journal:  Mol Cell Biochem       Date:  2009-02-18       Impact factor: 3.396

9.  Gene-based evaluation of low-frequency variation and genetically-predicted gene expression impacting risk of keloid formation.

Authors:  Jacklyn N Hellwege; Shirley B Russell; Scott M Williams; Todd L Edwards; Digna R Velez Edwards
Journal:  Ann Hum Genet       Date:  2018-02-27       Impact factor: 1.670

10.  Admixture mapping identifies a locus at 15q21.2-22.3 associated with keloid formation in African Americans.

Authors:  Digna R Velez Edwards; Krystal S Tsosie; Scott M Williams; Todd L Edwards; Shirley B Russell
Journal:  Hum Genet       Date:  2014-10-04       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.